1,2,11,12-tetrahydroxy-16-oxo-11,20-epoxypicras-3-en-15-yl 2-(acetyloxy)-2-methylbutanoate (68703-93-5)

Identification
Name:	1,2,11,12-tetrahydroxy-16-oxo-11,20-epoxypicras-3-en-15-yl 2-(acetyloxy)-2-methylbutanoate
Synonyms:	NSC297898;Glaucarubine-2'-acetate;AC1L6YEY;GLAUCARUBINE, 2'-ACETYL;NSC-297898;68703-93-5
CAS:	68703-93-5
Molecular Formula:	C₂₇H₃₈O₁₁
Molecular Weight:	538.584
InChI:	InChI=1/C27H38O11/c1-7-24(5,38-13(4)28)23(33)37-18-17-12(3)19(30)27(34)22-25(6)14(11(2)8-15(29)20(25)31)9-16(36-21(18)32)26(17,22)10-35-27/h8,12,14-20,22,29-31,34H,7,9-10H2,1-6H3
Molecular Structure:
Properties
Flash Point:	229.6°C
Boiling Point:	701.6°C at 760 mmHg
Density:	1.41g/cm³
Refractive index:	1.597
Flash Point:	229.6°C
Safety Data

Other Product

bis{12-(acetyloxy)-11-hydroxy-21-methoxy-15-[(3-methylbut-2-enoyl)oxy]-2,16,21-trioxo-13,20-epoxypicras-3-en-3-yl} butanedioate
(1beta,12alpha,15beta)-1,11,12-trihydroxy-2,16-dioxo-11,20-epoxypicras-3-en-15-yl 2-(acetyloxy)-2-methylbutanoate
(1beta,2alpha,6alpha,11alpha,12alpha)-1,2,11,12-tetrahydroxy-16-oxo-11,20-epoxypicras-3-en-6-yl (2E)-2-methylbut-2-enoate
(1beta,6alpha,12alpha)-1,12-bis(acetyloxy)-11-hydroxy-2,16-dioxo-11,20-epoxypicras-3-en-6-yl 3-methylbut-2-enoate
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
Kaur-16-en-15-one,3,6,7-tris(acetyloxy)-2,- 11-dihydroxy-,(2â,3â,6R,7â,11â)-
Kaur-16-en-15-one,2,6,7-tris(acetyloxy)-3,- 11-dihydroxy-,(2â,3â,6R,7â,11â)-
methyl (11beta,12alpha,13beta,15beta)-12-(acetyloxy)-11-hydroxy-3,15-bis[(3-methylbut-2-enoyl)oxy]-2,16-dioxo-13,20-epoxypicras-3-en-21-oate
Kaur-16-en-15-one,2,3,7-tris(acetyloxy)-6,- 11-dihydroxy-,(2â,3â,6R,7â,11â)-
Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''(3''H)-furan]-11',22'-diol,1',- 3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'a,7',9',9'a,9'b,10',- 11',11'a,11'b,12',14'a,15',15'a,15'b,16',17',17'a,- 18',20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',5'',9'a,11'a,12',- 20'a,22'a-decamethyl-,(1'S,2R,2''S,3'aS,4'aR,- 4'bR,6'aS,9'aS,9'bS,11'R,11'aS,11'bR,12'S,- 14'aS,15'aR,15'bR,17'aS,20'aS,20'bS,22'R,22'aS,- 22'bR)-
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
Pregn-5-en-20-one,11-(acetyloxy)-3,8,14-trihydroxy-12-[(1-oxo-3-phenyl-2-propenyl)oxy]-, (3b,11a,12b,14b)- (9CI)
Dispiro[furan-2(3H),2'(13'H)-bisfuro[3'',2'':3',4']- cyclopenta[1',2':5,6]naphtho[1,2-b:1',2'-i]- phenazine-13',2''-[2H]pyran]-5'',11',22'-triol,1',3'',3'a,4,4',4'',4'a,4'b,5,5',5'',6',6'',6'a,7',9',9'a,- 9'b,10',11',11'a,11'b,12',14'a,15'b,16',17',17'a,18',- 20',20'a,20'b,21',22',22'a,22'bhexatriacontahydro- 1',5,5,5'',9'a,11'a,12',20'a,- 22'a-nonamethyl-,(1'S,2R,2''R,3'aS,4'aR,4'bR,- 6''S,6'aS,9'aS,9'bS,11'R,11'aR,11'bR,12'S,14'aS,- 15'bR,17'aS,20'aS,20'bS,22'R,22'aS,22'bR)-
[(2S,3S,4R,6S)-6-[(2R,3S,4S,5R,6S)-6-[[(2R,4E,6E,8R,9R,11R,12S,13S,14R)-14-acetyloxy-8-hydroxy-13-methoxy-2,9-dimethyl-16-oxo-11-(2-oxoethyl)-1-oxacyclohexadeca-4,6-dien-12-yl]oxy]-4-dimethylamino-5-hydroxy-2-methyl-oxan-3-yl]oxy-4-hydroxy-2,4-dimethyl-oxan-3-yl] 3-methylbutanoate; (2R,3R)-2,3-dihydroxybutanedioic acid
Kaur-16-en-15-one,3,7,11-tris(acetyloxy)-2,- 6-dihydroxy-,(2â,3â,6R,7â,11â)-
Kaur-16-en-15-one,3,7-bis(acetyloxy)-2,6,11- trihydroxy-,(2â,3â,6R,7â,11â)-
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
Formamide,N-[11-[16-(acetyloxy)-12-hydroxy-10,22-dimethoxy-11,14,21-trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,24,26(29),28-heptaen-20-yl]-4,10-dimethoxy-3,5,9-trimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
1/C18H32O3/c1-2-3-4-5-6-7-8-11-14-17(19)15-12-9-10-13-16-18(20)21/h11,14H,2-10,12-13,15-16H2,1H3,(H,20,21)/b14-11